The current market for pharmaceutical grade sodium carbonate is valued at USD 46.7 million in 2024 and is forecast to reach ...

NINER Pharmaceutical, a leading name in the pharmaceutical sector, announces its strategic expansion into the U.S. and Latin American markets to address critical shortages of IV fluids. Responding to ...

Azurity Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved Danziten™, the first and only nilotinib with no mealtime restrictions indicated for adult patients ...

The U.S. Agency for International Development (USAID) has committed $2.3 million to procure 4.8 million doses of life-saving malaria tablets from Swiss Pharma (Swipha) in a landmark partnership that ...

Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Continued Listing on Nasdaq ...

PSL is to exhibit at PMEC India this week, on stand F50, Hall 6 of the Bombay Exhibition Centre, Mumbai. The event runs 3-5 December. PSL is an international manufacturer of filtration, drying and ...

The authorised ANDA is a therapeutic equivalent of the reference-listed drug (RLD), Corlanor tablets, in the same 5 mg and ...

Alembic Pharmaceuticals Ltd received final approval on Tuesday from the United States Food and Drug Administration (USFDA) ...

The pharmaceutical gelatin market is driven by increasing demand for capsules, new drug delivery methods, and plant-based options. Heightened research and development in pharmaceuticals along with the ...

Increasing demand for the bentonite applications such as sealants, clarification agents, and adsorbents/absorbents in the end-use industries like construction, food, and pharmaceutical industry will ...

Romaco will be taking advantage of this year’s CPHI & PMEC India to show its complete processing portfolio for granulating, ...

The global oral solid dosage pharmaceutical formulation market is poised for remarkable expansion, with projections indicating a growth from USD 629,582.6 million in 2024 to USD 895,636.0 million by ...